Stay updated on Flotetuzumab in PIF/ER AML Clinical Trial

Sign up to get notified when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Flotetuzumab in PIF/ER AML Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, indicating access is blocked. The additions include the HTML structure of a 403 page (title, header, and footer) rather than substantive study details.
    Difference
    21%
    Check dated 2026-09-20T20:25:41.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    The page now shows revision v3.6.6, replacing the previous v3.6.5. This reflects a small deployment update with no documented changes to the study details or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-08-30T21:43:29.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The study page now displays a server error page with a basic HTML frame. This replaces the full study record and related content on the page.
    Difference
    20%
    Check dated 2026-08-09T11:19:50.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    The page revision tag was updated from v3.6.3 to v3.6.4, signaling a small backend/content update with no visible changes to the study details shown to users.
    Difference
    0.0%
    Check dated 2026-07-26T00:08:40.000Z thumbnail image
  7. Check
    93 days ago
    Change Detected
    Summary
    Page build updated from v3.6.2 to v3.6.3. This reflects a new release of the page rather than content changes.
    Difference
    0.0%
    Check dated 2026-07-04T13:32:51.000Z thumbnail image
  8. Check
    100 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.0 to v3.6.2, indicating a new release of the page’s software. This update likely represents minor fixes or improvements behind the scenes rather than user-facing content changes.
    Difference
    0.0%
    Check dated 2026-06-27T07:44:35.000Z thumbnail image

Stay in the know with updates to Flotetuzumab in PIF/ER AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Flotetuzumab in PIF/ER AML Clinical Trial page.